Cell Therapies & Biologics
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
119
NCT01731093
Safety and Tolerability of Antioxidant (AT-001)for Reducing Brain Oxidative Stress
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 31, 2012
Completion: Dec 31, 2013
NCT03062384
AT-001 for Long-term Preservation of Brain Health in Aging
Phase: N/A
Role: Collaborator
Start: May 31, 2016
Completion: Dec 31, 2018
Loading map...